Oncology Pipeline 2025: Emerging Breakthroughs and Trends​

Pricing: Free for Members and Non-Members

Course Description

Oncology remains one of the medical areas with the highest innovation. Novel oncology mechanisms, including multi-specific antibodies, antibody drug conjugates, and cell and gene therapy, have grown to account for 25% of oncology trials. In 2024 and continuing into 2025, many new oncology entities launched in the U.S., spanning solid tumors and hematologic indications. Global spending on cancer medication was estimated at $223 billion in 2023 and is on track to reach $409 billion by 2028. This session will cover key agents recently approved by the FDA or in late-stage development, focusing on novel mechanisms of action. The potential impact on current standards of care and what this may mean for payers will be discussed.

Target Audience

Pharmacists who practice in managed care settings.

Learning Objectives

At the completion of this activity, participants should be able to:

  1. Identify recently approved and upcoming approvals of high-impact oncology specialty drugs for solid and hematologic malignancies.
  2. Differentiate the mechanisms of action, indications, safety, and efficacy of newly approved and emerging oncology specialty medications.
  3. Assess the impact of new and emerging approvals of oncology specialty medications on cost considerations, contracting, benefit formularies, and other managed care processes.

Commercial Support

This activity is supported by an independent medical education grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.

Course summary
Available credit: 
  • 1.25 ACPE
    The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
11/13/2025
Course expires: 
12/31/2026
Cost:
$0.00

Sita Bhatt, PharmD, BCOP

Clinical Pharmacy Specialist
Boston Medical Center
Boston, MA

Kaelyn C. Boss, PharmD

Clinical Consultant Pharmacist
ForHealth Consulting University of Massachusetts Chan Medical School
Shrewsbury, MA

Disclosures

Faculty/Reviewer/Planner​

Reported Relevant Financial Relationships​

Sita Bhatt 
Faculty		Disclosed no relevant financial relationships.​
Kaelyn C. Boss 
Faculty 

Disclosed no relevant financial relationships.​

Casey Koch
Peer Reviewer

Disclosed no relevant financial relationships.​

Jennifer Evans 
Planner		Disclosed no relevant financial relationships.​

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE UAN: 0233-0000-25-063-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: November 13, 2025 •  Expiration Date: December 31, 2026
Activity Fee: Free for Members and Non-Members

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2025. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

Available Credit

  • 1.25 ACPE
    The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$0.00
Please login or register to take this course.